• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>MedImmune

MedImmune

  1. All
  2. Morningstar Articles
  3. 3rd Party
  4. Investing
  1. ADC Therapeutics Appoints Dr. Chris Martin as Chief Executive Officer

    ADC Therapeutics Appoints Dr. Chris Martin as Chief Executive Officer

  2. Immune Pharmaceuticals Initiates Phase II Clinical Trials With Bertilimumab In Ulcerative Colitis And Bullous Pemphigoid

    Immune Pharmaceuticals Initiates Phase II Clinical Trials With Bertilimumab In Ulcerative Colitis And Bullous Pemphigoid

  3. Research and Markets: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

    Research and Markets: Recurrent Head And Neck Cancer Squamous Cell Carcinoma - Pipeline Review, H1 2015

  4. Sosei Subsidiary Heptares Announces Positive Outcome of Phase 1a Study with First-Ever Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Patients with Alzheimer's Disease

    Sosei Subsidiary Heptares Announces Positive Outcome of Phase 1a Study with First-Ever Selective Muscarinic M1 Receptor Agonist for Improving Cognition in Patients with Alzheimer's Disease

  5. Advaxis's Cancer Immunotherapy Delays Progression of HER2+ Canine Osteosarcoma

    Advaxis's Cancer Immunotherapy Delays Progression of HER2+ Canine Osteosarcoma

  6. Research and Markets: Global Cutaneous T-Cell Lymphoma Therapeutics Pipeline Review, H1 2015

    Research and Markets: Global Cutaneous T-Cell Lymphoma Therapeutics Pipeline Review, H1 2015

  7. Research and Markets: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

    Research and Markets: Idiopathic Pulmonary Fibrosis - Pipeline Review, H1 2015

  8. Pharmaceutical Firms Get the Urge to Merge

    Morningstar analysts see pharmaceuticals as 2010's hot zone for mergers and acquisitions.

  9. Biotech Investing for the Long Haul

    Three ways to separate long-term winners from stocks that fizzle.

  10. Morningstar Indexes: Weekly Market Report

    Week ending April 27: Quarterly earnings continue to boost market's spirits. 

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.